-
’20 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PRE..
’20 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING,AMELIORATING, OR TREATING PROTEINOPATHIES ..
2021.06.10View more -
’20 P62 LIGAND COMPOUND AND ER-PHAGY-PROMOTING USE THEREOF (KR, WO)
’20 P62 LIGAND COMPOUND AND ER-PHAGY-PROMOTING USE THEREOF (KR, WO)Provided are a composition for promoting ER-phagy, a ..
2021.06.10View more -
’19 NOVEL AUTOPHAGY-TARGETING CHIMERA (AUTOTAC) COMPOUND, AND COMPOSIT..
’19 NOVEL AUTOPHAGY-TARGETING CHIMERA (AUTOTAC) COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING,OR TREATING DISEAS..
2021.06.10View more -
’19 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIA..
’19 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING,OR TREATING PROTEINOPATHIES COMPRISING SAME..
2021.06.10View more -
'19 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TR..
'19 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING ORTREATING OBESITY OR METABOLIC SYNDROME COMPRISING S..
2021.06.10View more -
’15 PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES THROUGH AUT..
’15 PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES THROUGH AUTOPHAGY ACTIVITY MEDIATED BY LIGAND OR ARGINYLATED ..
2021.06.10View more -
’13 METHOD FOR REGULATING P62 ZZ DOMAIN-MEDIATED AUTOPHAGY AND USE THE..
’13 METHOD FOR REGULATING P62 ZZ DOMAIN-MEDIATED AUTOPHAGY AND USE THEREOF (KR, WO)The present invention relates to: a..
2021.06.08View more